CA Stock MarketDetailed Quotes
VM Voyageur Pharmaceuticals Ltd
- 0.070
- 0.0000.00%
15min DelayTrading Jul 2 09:30 ET
9.72MMarket Cap-7777P/E (TTM)
0.070High0.070Low43.30KVolume0.070Open0.070Pre Close3.03KTurnover0.09052wk High0.04%Turnover Ratio138.88MShares0.03552wk Low-0.009EPS TTM8.72MFloat Cap0.400Historical HighLossP/E (Static)124.63MShs Float0.035Historical Low-0.01EPS LYR0.00%Amplitude--Dividend TTM6.36P/B1Lot Size--Div YieldTTM
Voyageur Pharmaceuticals Ltd Key Stats
Quarterly+Annual
YOY
| (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | (Q3)Aug 31, 2022 | (Q2)May 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 61.39%-183.07K | 42.33%-991.25K | 116.21%29.56K | 93.86%-67.48K | -323.22%-479.13K | -46.31%-474.2K | -4.27%-1.72M | 60.29%-182.39K | -272.47%-1.1M | 80.92%-113.21K |
| Net income from continuing operations | 11.97%-328.95K | 20.21%-1.4M | 50.88%-282.33K | 71.48%-121.96K | -23.28%-621.49K | -51.08%-373.69K | 14.51%-1.75M | -11.00%-574.78K | 61.87%-427.63K | -51.71%-504.14K |
| Operating gains losses | --1.25K | -119.92%-1.24K | ---17.59K | --0 | ---- | ---- | --6.21K | ---- | ---- | ---- |
| Depreciation and amortization | -28.02%393 | -76.28%2.19K | -92.23%546 | -24.76%547 | -24.90%546 | -24.90%546 | 11.98%9.21K | -14.54%7.03K | --727 | --727 |
| Asset impairment expenditure | ---- | --48.61K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Remuneration paid in stock | 367.25%125.07K | 12.90%234.03K | -87.39%12.22K | -124.60%-27.16K | --222.21K | --26.77K | -71.90%207.29K | 589.95%96.89K | --110.4K | --0 |
| Other non cashItems | ---1 | -74.21%14.48K | --14.48K | ---- | ---- | ---- | --56.15K | ---- | ---- | ---- |
| Change In working capital | 114.99%19.17K | 145.19%110.15K | 12.17%253.63K | 110.36%81.09K | -124.79%-96.75K | -64.97%-127.82K | 28.87%-243.73K | 222.55%226.11K | -1,234.55%-782.56K | 249.55%390.2K |
| -Change in receivables | 228.36%18.08K | -168.26%-12.05K | -1,108.36%-9.29K | -44.27%17.72K | 26.13%-6.4K | -120.13%-14.08K | 161.14%17.65K | 111.01%921 | 803.21%31.79K | -10.09%-8.66K |
| -Change in inventory | --0 | --0 | ---- | ---- | ---- | --0 | -463.10%-610 | ---- | ---- | ---- |
| -Change in prepaid assets | -4,816.94%-131.18K | 174.84%51.12K | -60.24%16.9K | 90.13%-11.65K | 5,004.21%48.54K | -142.46%-2.67K | -195.72%-68.31K | 187.49%42.5K | -315.13%-118.04K | 101.04%951 |
| -Change in payables and accrued expense | 219.09%132.27K | 136.93%71.08K | 34.21%246.02K | 110.77%75.02K | -134.90%-138.89K | -43.56%-111.07K | 33.83%-192.46K | 187.29%183.3K | -3,757.45%-696.31K | 345.94%397.91K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 61.39%-183.07K | 42.33%-991.25K | 116.21%29.56K | 93.86%-67.48K | -323.22%-479.13K | -46.31%-474.2K | -4.27%-1.72M | 60.29%-182.39K | -272.47%-1.1M | 80.92%-113.21K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 10.44%-37.55K | 36.27%-174.72K | 11.66%-33.21K | 15.65%-54.74K | -291.95%-44.85K | 78.51%-41.92K | 37.42%-274.15K | 79.73%-37.59K | 46.48%-64.89K | 153.31%23.37K |
| Capital expenditure reported | ---- | ---- | ---- | 38.90%-141.52K | ---- | ---- | ---- | ---- | ---231.61K | --0 |
| Net PPE purchase and sale | ---- | --0 | --0 | ---- | ---- | ---- | --8.76K | --11.24K | ---- | ---- |
| Net other investing changes | 10.44%-37.55K | 38.24%-174.72K | ---- | ---- | -291.95%-44.85K | 78.23%-41.92K | 35.42%-282.91K | ---- | ---- | 178.62%23.37K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 10.44%-37.55K | 36.27%-174.72K | 11.66%-33.21K | 15.65%-54.74K | -291.95%-44.85K | 78.51%-41.92K | 37.42%-274.15K | 79.73%-37.59K | 46.48%-64.89K | 153.31%23.37K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -58.80%468.28K | -6.19%1.14M | 129.61%3.85K | 0 | -145.79%-3.85K | 3,760.51%1.14M | -58.17%1.21M | -39.06%-13.01K | 514.68%1.19M | -99.56%8.41K |
| Net issuance payments of debt | ---- | --0 | --0 | --0 | ---- | ---- | 12.18%-16.56K | 6.29%-8.76K | -148.90%-4.64K | 25.28%-1.59K |
| Net common stock issuance | -58.86%493.6K | -3.70%1.2M | 190.80%3.85K | --0 | ---3.85K | --1.2M | -45.94%1.25M | ---4.24K | --1.25M | --0 |
| Proceeds from stock option exercised by employees | ---- | --0 | ---- | ---- | ---- | ---- | -94.78%41K | --0 | --0 | -97.79%10K |
| Net other financing activities | 60.09%-25.32K | -7.54%-63.45K | --0 | --0 | --0 | ---63.45K | 66.47%-59K | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -58.80%468.28K | -6.19%1.14M | 129.61%3.85K | --0 | -145.79%-3.85K | 3,760.51%1.14M | -58.17%1.21M | -39.08%-13.01K | 514.68%1.19M | -99.56%8.41K |
| Net cash flow | ||||||||||
| Beginning cash position | -93.39%2.09K | -96.12%31.56K | -99.29%1.88K | -48.68%124.1K | 101.67%651.94K | -96.12%31.56K | 27,300.30%812.97K | -81.97%264.54K | -85.69%241.83K | -25.85%323.27K |
| Current changes in cash | -60.08%247.67K | 96.23%-29.48K | 100.09%203 | -638.30%-122.22K | -548.18%-527.83K | 226.68%620.37K | -196.47%-781.41K | 64.38%-232.98K | 110.17%22.71K | -106.49%-81.43K |
| End cash Position | -61.69%249.75K | -93.39%2.09K | -93.39%2.09K | -99.29%1.88K | -48.68%124.1K | 101.67%651.94K | -96.12%31.56K | -96.12%31.56K | -81.97%264.54K | -85.69%241.83K |
| Free cash from | 61.39%-183.07K | 42.33%-991.25K | 215.76%171.07K | 84.32%-209K | -323.22%-479.13K | -45.20%-474.2K | -4.27%-1.72M | 111.80%54.18K | -374.49%-1.33M | 81.36%-113.21K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg